Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


A Risk Scores for Predicting Prevalence of Diabetes in the LAO Population
Condition:   Undiagnosed Diabetes
Intervention:  
Sponsor:   Chulalongkorn University
Completed

Tue, 17 Oct 2017 12:00:00 EDT


A Study of LY3298176 in Participants With Type 2 Diabetes
Condition:   Type 2 Diabetes
Interventions:   Drug: LY3298176;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Not yet recruiting

Tue, 17 Oct 2017 12:00:00 EDT


Association of Type 1 Diabetes Mellitus in Offsprings With Positive Parental History of Diabetes
Condition:   Type 1 Diabetes
Intervention:   Drug: Blood draw for insulin auto-anti body tests*
Sponsor:   Sanofi
Not yet recruiting

Tue, 17 Oct 2017 12:00:00 EDT


EVALUATION OF A NEW FUNCTIONAL INSULIN THERAPY
Condition:   Type1diabetes
Interventions:   Other: New functional insulin therapy;   Other: functional insulin therapy
Sponsors:   Central Hospital, Nancy, France;   Central Hospital, Reims, France;   Central Hospital, Toulouse, France;   Central Hospital, Strasbourg, France;   Central Hospital, Besançon, France;   Central Hospital, Dijon, France;   Central Hospital, Metz Thionville, France
Not yet recruiting

Tue, 17 Oct 2017 12:00:00 EDT


Effects of Primary Prevention in Elderly People-The Healthy Aging Initiative
Conditions:   Cardiovascular Diseases;   Non-communicable Disease
Intervention:   Behavioral: Intervention group
Sponsor:   Västerbotten County Council
Enrolling by invitation

Tue, 17 Oct 2017 12:00:00 EDT


Locally Delivered 1% Metformin Gel in Peri-implantitis
Condition:   Peri-Implantitis
Interventions:   Drug: 1% local metformin gel;   Procedure: Placebo
Sponsor:   King Saud University
Completed

Tue, 17 Oct 2017 12:00:00 EDT


STEMI and Incretins
Conditions:   STEMI;   Coronary Artery Disease;   Coronary Syndrome;   Coronary Arteriosclerosis;   Diabetes
Interventions:   Device: PCI and DES stenting;   Drug: Incretins
Sponsor:   University of Campania "Luigi Vanvitelli"
Completed

Tue, 17 Oct 2017 12:00:00 EDT


An Assessment of Pharmacokinetic Gemigliptin and Metformin Interactions in Healthy Mexican Volunteers
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Gemigliptin;   Drug: Gemigliptin 50 mg q.d. + metformin 1000 mg twice a day;   Drug: Metformin
Sponsors:   Stendhal Americas, S.A.;   Universidad Nacional Autonoma de Mexico;   LG Chem
Completed

Mon, 16 Oct 2017 12:00:00 EDT


Aortic Stenosis in Subjects With Heterozygous Familial Hypercholesterolemia on Prolonged Treatment With Statins
Conditions:   Aortic Stenosis;   Arteriosclerosis;   Familial Hypercholesterolemia;   Conventional Transthoracic Echocardiogram
Intervention:   Procedure: Echocardiogram
Sponsor:   Instituto Aragones de Ciencias de la Salud
Recruiting

Mon, 16 Oct 2017 12:00:00 EDT


Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects
Conditions:   Type 1 Diabetes Mellitus;   Type 2 Diabetes Mellitus
Intervention:   Drug: sotagliflozin (SAR439954)
Sponsor:   Sanofi
Not yet recruiting

Mon, 16 Oct 2017 12:00:00 EDT


Variation of Genes Controlling Carbohydrate and Lipid Metabolism
Conditions:   Diabetes Mellitus, Type 2;   Cardiovascular Diseases;   Obesity;   Insulin Resistance;   Lipid Metabolism Disorders;   PreDiabetes
Intervention:  
Sponsors:   Turku University Hospital;   University of Eastern Finland;   Kuopio University Hospital;   University of Turku
Recruiting

Mon, 16 Oct 2017 12:00:00 EDT


A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes
Conditions:   PreDiabetes;   Aging
Interventions:   Drug: Metformin;   Drug: Placebo Oral Tablet
Sponsor:   University of New Mexico
Recruiting

Fri, 13 Oct 2017 12:00:00 EDT


Disease Prevention in Clinical Practice Base on Patient Specific Physiology
Conditions:   PreDiabetes;   Insulin Resistance;   Type2 Diabetes;   NASH - Nonalcoholic Steatohepatitis;   Diastolic Dysfunction;   Dementia;   Atrial Fibrillation;   Cancer;   Atherosclerosis;   Carotid Plaque
Intervention:   Other: Lifestyle modification in routine care of patients
Sponsor:   Pacific Coast Family Medical Group
Enrolling by invitation

Fri, 13 Oct 2017 12:00:00 EDT


Role of Glycaemic Index and High Protein Meal in Response of Blood Biomarkers for Pre-diabetes
Condition:   Pre Diabetes
Interventions:   Other: High Glycemic Index;   Other: Low Glycemic Index
Sponsors:   Clinical Nutrition Research Centre, Singapore;   University of Auckland, New Zealand;   Massey University;   Riddet University
Active, not recruiting

Fri, 13 Oct 2017 12:00:00 EDT


Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
Conditions:   Liver Diseases, Alcoholic;   Fibrosis
Interventions:   Diagnostic Test: transient elastography;   Diagnostic Test: Enhanced liver fibrosis test;   Diagnostic Test: Indirect serum markers of liver fibrosis;   Diagnostic Test: Direct serum markers of liver fibrosis;   Diagnostic Test: LiverTRAIL;   Diagnostic Test: Cytokeratin 18;   Diagnostic Test: Omics markers
Sponsors:   Maja Thiele;   European Commission, H2020;   Novo Nordisk A/S;   University of Southern Denmark;   Esbjerg University Hospital of South-West Jutland;   Odense Municipality Alcohol Rehabilitation Unit;   Svendborg Municipality Alcohol Rehabilitation Unit;   University of Copenhagen;   University of Oslo;   Nordic Bioscience A/S;   VLV Bio, Peviva AB;   Manatee APS;   Siemens Healthcare A/S;   Steno Diabetes Center;   Biomedical Research Foundation, Academy of Athens;   European Molecular Biology Laboratory, EMBL, University of Heidelberg
Recruiting

Fri, 13 Oct 2017 12:00:00 EDT
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


FDA clears new robotically-assisted surgical device for adult patients
Today, the U.S. Food and Drug Administration cleared the Senhance System, a new robotically-assisted surgical device (RASD) that can help facilitate minimally invasive surgery.

Fri, 13 Oct 2017 16:14:00 -0400


California dietary supplement maker, Custompax prohibited from manufacturing
A California dietary supplement manufacturer recently was ordered by a federal court to stop selling its products until the company comes into compliance with the U.S. Food and Drug Administration’s dietary supplement manufacturing regulations and other requirements listed in a consent decree.

Fri, 13 Oct 2017 12:14:00 -0400


Statement by FDA Commissioner Scott Gottlieb, M.D. on Baxter manufacturing recovery in Puerto Rico
Statement by FDA Commissioner Scott Gottlieb, M.D. on Baxter manufacturing recovery in Puerto Rico

Fri, 13 Oct 2017 08:31:00 -0400


FDA clears first 7T magnetic resonance imaging device
Today, the U.S. Food and Drug Administration cleared the first seven tesla (7T) magnetic resonance imaging (MRI) device, more than doubling the static magnetic field strength available for use in the United States. The Magentom Terra is the first 7T MRI system cleared for clinical use in the United States.

Thu, 12 Oct 2017 10:45:00 -0400


Statement by FDA Commissioner Scott Gottlieb, M.D. on new steps by FDA to advance patient engagement in the agency’s regulatory work
The Food and Drug Administration is hosting a pioneering event today: the first meeting of the Patient Engagement Advisory Committee or PEAC. It’s a significant step forward in the FDA’s efforts to broaden its engagement with patients – and to deepen the involvement of patients in our regulatory activities.

Wed, 11 Oct 2017 11:52:00 -0400


FDA approves implantable device to treat moderate to severe central sleep apnea
The U.S. Food and Drug Administration today approved a new treatment option for patients who have been diagnosed with moderate to severe central sleep apnea. The Remedē System is an implantable device that stimulates a nerve located in the chest that is responsible for sending signals to the diaphragm to stimulate breathing.

Fri, 06 Oct 2017 16:55:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s continued assistance following the natural disaster in Puerto Rico
FDA continues extensive efforts to provide direct assistance to the residents of Puerto Rico following Hurricanes Irma and Maria, and is taking new steps to mitigate the impact of these twin disasters on the island’s vibrant medical product manufacturing sector. Our top priority is the people of Puerto Rico.

Fri, 06 Oct 2017 15:23:00 -0400


FDA awards 15 grants for clinical trials to stimulate product development for rare diseases
The U.S. Food and Drug Administration today announced that it has awarded 15 new clinical trial research grants totaling more than $22 million over the next four years to boost the development of products for patients with rare diseases. These new grants were awarded to principal investigators from academia and industry across the country.

Fri, 06 Oct 2017 10:33:00 -0400


FDA awards six grants for natural history studies in rare diseases
The U.S. Food and Drug Administration today announced it has awarded six new research grants for natural history studies in rare diseases. The aim of the research is to inform medical product development by better understanding how specific rare diseases progress over time. One potential application of these studies is the opportunity to eventually use natural history models to augment the need for placebo arms in studies of drugs that target very rare disease, where trial recruitment can be challenging.

Fri, 06 Oct 2017 10:32:00 -0400


FDA approves first test for screening Zika virus in blood donations
The U.S. Food and Drug Administration today approved the cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual plasma specimens obtained from volunteer donors of whole blood and blood components, and from living organ donors.

Thu, 05 Oct 2017 17:04:00 -0400
Diabetes news from the American Diabetes Association

Latest Top (5) News